Eigen Peralta

Title: Innovations by Eigen Peralta in Immune Cell Modulation

Introduction

Eigen Peralta, an inventive mind located in San Diego, California, has made significant contributions to the field of immunotherapy through his innovative inventions. With a total of six patents to his name, his work focuses on advancing adoptive immunotherapies by modulating immune cells. His research highlights the potential to enhance therapeutic efficacy in treating various solid tumors.

Latest Patents

Eigen's latest patents include groundbreaking compositions and methods for immune cell modulation. One significant patent details compositions intended for immune cell modulation in adoptive immunotherapies. This patent identifies compounds that increase the proportion and absolute number of crucial immune cell types, including naïve, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells.

Another important innovation by Eigen focuses on functionally enhanced derivative effector cells obtained from genomically engineered induced pluripotent stem cells (iPSCs). This patent provides methods and compositions that create cells with a stable and functional genome editing capability, improving therapeutic outcomes. The therapeutic compositions derived from these enhanced cells can be utilized alone or in combination with antibodies or checkpoint inhibitors to achieve superior treatment effects.

Career Highlights

Throughout his career, Eigen Peralta has worked with prominent companies that are at the forefront of biotechnological advancements. Notable firms include Fate Therapeutics, Inc., and Juno Therapeutics GmbH. His roles in these companies have allowed him to develop and refine his groundbreaking inventions, contributing to progress in the field of immunotherapy.

Collaborations

During his journey, Eigen has collaborated with other notable professionals in the industry, including Jonathan Rosen and Betsy Rezner. These collaborations have undoubtedly enriched his research and fostered an environment of innovation, ultimately leading to the development of transformative therapies aimed at improving patient outcomes.

Conclusion

Eigen Peralta's work stands as a testament to the potential of innovative thinking in the medical and therapeutic fields. His contributions in the realm of immune cell modulation through his patents are paving the way for advanced treatments in immunotherapy, showcasing the importance of inventors in transforming scientific ideas into practical applications.